AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Flat index levels can mask underlying shifts among components; still, broader market movements may occur through price changes in parts.
28,641 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
SharpLink has returned to ETH purchases after an eight-month hiatus, buying around $8 million of ETH. At the same tim...
When a Utah boy kept his 4-H pig Dave, the internet cheered and learned a money lesson at the same time. This is more...
A rising share of foreclosure auction purchases are going to owner-occupants, signaling a shift in affordability and ...
SanDisk, Micron and Western Digital nosedived as investors cash in after a rapid AI memory rally, signaling a pause i...
Pennsylvania's House is set to vote on HB 2120 to bring home equity investment contracts under state banking oversigh...
Nvidia’s quarterly print arrives amid an AI demand cycle that remains uneven. Analysts say nvidia earnings don’t matt...
As the space economy expands, investors face a big question: spacex rocket lab: which stock deserves a place in a gro...
Apple warns memory costs may squeeze margins and push pricing for the iPhone 18 cycle. Investors are weighing how you...
Salesforce delivered a solid Q4 beat and announced a $50 billion buyback, but FY27 guidance disappointed investors. T...
IonQ is leading the field among pure-play quantum stocks in 2026, delivering a positive year-to-date return while its...
As travel rebounds, premium demand is reshaping cruise stock dashboards. This deep dive explains why norwegian cruise...